C6K0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 11.26 EUR 2.74% Market Closed

Market Cap: €204.1m

	Avalo Therapeutics Inc F:C6K0	US
	APAQ Technology Co Ltd TWSE:6449	TW
B	BYD Co Ltd XMUN:BY6	CN
	Q linea AB F:3F80	SE
C	Champion Pacific Indonesia Tbk PT XMUN:IUD	ID
	CF Industries Holdings Inc NYSE:CF	US
	Reckitt Benckiser Group PLC F:3RB	UK

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

105%

Gross Margin is Increasing

81% > 100%

Negative Operating Margin

-123 602%

Negative 3Y Average Operating Margin

-18 716%

Declining Operating Margin

-146% > -123 602%

Negative Net Margin

-132 642%

Negative 3Y Average Net Margin

-21 305%

Declining Net Margin

-170% > -132 642%

Negative Free Cash Flow Margin

-87 217%

Negative 3Y Average Free Cash Flow Margin

-14 686%

Declining Free Cash Flow Margin

-121% > -87 217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-281%

Declining ROIC

-151% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.